1. Home
  2. Analysis
  3. Horizant
  4. Sucralfate

Horizant and Sucralfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 11 people who take Horizant and Sucralfate. Common interactions include abnormal dreams among females, and asthenia among males.

The phase IV clinical study analyzes what interactions people who take Horizant and Sucralfate have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

11 people who take Horizant and Sucralfate together, and have interactions are studied.

What is Horizant?

Horizant has active ingredients of gabapentin enacarbil. It is used in restless leg syndrome. Currently, eHealthMe is studying from 2,000 Horizant users.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 16,349 Sucralfate users.

Number of Horizant and Sucralfate reports submitted per year:

Horizant and Sucralfate drug interactions.

Common Horizant and Sucralfate drug interactions by gender *:

female:

  1. Abnormal dreams
  2. Anger
  3. Dizziness
  4. Energy increased
  5. Euphoric mood
  6. Fatigue
  7. Gastrointestinal disorder
  8. Headache
  9. Hypersomnia
  10. Initial insomnia

male:

  1. Asthenia
  2. Blood pressure decreased
  3. Hypoaesthesia
  4. Hypophagia
  5. Insomnia
  6. Intracranial hypotension
  7. Migraine
  8. Muscle tightness
  9. Muscular weakness
  10. Occipital neuralgia

Common Horizant and Sucralfate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthenia
  2. Blood pressure decreased
  3. Cervical radiculopathy
  4. Disturbance in attention
  5. Fatigue
  6. Gastrointestinal haemorrhage
  7. Hepatitis
  8. Hypophagia
  9. Intracranial hypotension
  10. Migraine

40-49:

n/a

50-59:

  1. Euphoric mood
  2. Fatigue
  3. Hypersomnia
  4. Initial insomnia
  5. Insomnia
  6. Irritability
  7. Mania
  8. Nightmare
  9. Psychomotor hyperactivity
  10. Abnormal dreams

60+:

  1. Bone pain
  2. Dyskinesia
  3. Formication
  4. Hypoaesthesia
  5. Insomnia
  6. Muscle tightness
  7. Muscular weakness

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 45.45%
  2. Sleep Disorder: 2 people, 18.18%
  3. Wrist Fracture: 1 person, 9.09%
  4. Upper Limb Fracture: 1 person, 9.09%
  5. Stress And Anxiety: 1 person, 9.09%
  6. Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
  7. Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
  8. Migraine (headache): 1 person, 9.09%
  9. High Blood Pressure: 1 person, 9.09%
  10. Gastric Ulcer (stomach ulcer): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Horizant and Sucralfate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Horizant drug interactions:

Browse interactions between Horizant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sucralfate drug interactions:

Browse interactions between Sucralfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin enacarbil and sucralfate (the active ingredients of Horizant and Sucralfate, respectively), and Horizant and Sucralfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Horizant and Sucralfate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.